Risk of diabetic retinopathy between sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists (Diabetes Metab J 2023;47:394-404)
Las dos estimulan la secrecin de insulina de manera dependiente de glucosa, minimizando el riesgo de hipoglucemia
All products referenced are sold as research-grade compounds for laboratory use, are Research Use Only, and are Not for Human Consumption
Mecanismo de ao Estimula a secreo de insulina (glicose-dependente) Inibe a secreo de glucagon Retarda o esvaziamento gstrico Reduz o apetite via ao no hipotlamo Melhora o controle glicmico ps-prandial Pode contribuir com neuroproteo e sade cardiovascular Aplicaes teraputicas Relao com a indstria farmacutica Os medicamentos baseados em GLP-1 se tornaram uma das classes teraputicas de maior crescimento da indstria farmacutica global
13,49,50 Meng et al, in their study on mouse-isolated hepatocytes, reported that a low concentration of metformin (25100 M) activated AMPK, whereas a higher concentration (500 M) inhibited it
Quick, private, and no commitment to continue
